Device Trial Radar · NCT03073148
Evaluation of Tangible Boost Replenishing System
Last checked: Nov 19, 2026Latest source record: Nov 17, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
35
Actual
Start
Feb 24, 2017
Primary completion
Feb 13, 2019
Study completion Feb 13, 2019
Sponsor
- Lead sponsor
- Tangible ScienceNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- University of Houston
- First posted
- Mar 8, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, care provider)
- Primary purpose
- Supportive care
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate Tangible Boost, a new contact lens care product which is designed to replenish the hydrogel layer on fluorosilicone acrylate lenses with Hydra-PEG. The Hydra-PEG coating is a poly(ethylene glycol)-based hydrogel that is covalently bound to the lens surface. This coating improves lens wettability, a common cause of patient discomfort. Tangible Boost is designed to maintain the wettability of Hydra-PEG lenses throughout the lens lifetime. Patients can use the Tangible Boost kit to reapply the Hydra-PEG coating each month at home.
Conditions
- Contact Lens Solution
Interventions
Tangible BoostDevice
Participants will treat their lenses with Tangible Boost, a kit designed to maintain the wettability of Hydra-PEG treated fluorosilicone acrylate lenses.
Placebo salineOther
Participants will treat their lenses with a placebo "Tangible Boost" kit, which contains saline in place of the Tangible Boost solution.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Patients With Adverse Event Reports or DiscontinuationsTime frame: Duration of study, 90 +/- 7 days after lens dispense visit.
- Corneal StainingTime frame: 1 day after treatment (day 31), final assessment (day 90)
- Visual AcuityTime frame: 1 day after treatment (day 31), final assessment (day 90)
2 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Houston
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.